120 related articles for article (PubMed ID: 23883196)
1. Current trends and investigative developments in celiac disease.
Samaşca G; Sur G; Lupan I
Immunol Invest; 2013; 42(4):273-84. PubMed ID: 23883196
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
[TBL] [Abstract][Full Text] [Related]
3. Romanian experience in child celiac disease diagnosis.
Samaşca G; Iancu M; Băican A; Bruchental M; Cherecheş-Panţa P; Fufezan O; Butnariu A; Farcău D; Burac L; Pop T; Pîrvan A; Slăvescu L; Miu N; Andreica M; Matinca D; Gheban D; Nechit R; Ponta M; Constantinescu I; Dejica D; Cristea V
Roum Arch Microbiol Immunol; 2011; 70(4):178-85. PubMed ID: 22568266
[TBL] [Abstract][Full Text] [Related]
4. Digesting all the options: laboratory testing for celiac disease.
Barakauskas VE; Lam GY; Estey MP
Crit Rev Clin Lab Sci; 2014 Dec; 51(6):358-78. PubMed ID: 25244521
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment.
Sugai E; Nachman F; Váquez H; González A; Andrenacci P; Czech A; Niveloni S; Mazure R; Smecuol E; Cabanne A; Mauriño E; Bai JC
Dig Liver Dis; 2010 May; 42(5):352-8. PubMed ID: 19679520
[TBL] [Abstract][Full Text] [Related]
6. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet.
Nachman F; Sugai E; Vázquez H; González A; Andrenacci P; Niveloni S; Mazure R; Smecuol E; Moreno ML; Hwang HJ; Sánchez MI; Mauriño E; Bai JC
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):473-80. PubMed ID: 21537123
[TBL] [Abstract][Full Text] [Related]
7. [Intolerance of gluten--a new disease or undiagnosed celiac disease].
Sabel'nikova EA
Eksp Klin Gastroenterol; 2012; (3):87-9. PubMed ID: 22830230
[TBL] [Abstract][Full Text] [Related]
8. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
Liu E; Li M; Emery L; Taki I; Barriga K; Tiberti C; Eisenbarth GS; Rewers MJ; Hoffenberg EJ
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):293-300. PubMed ID: 17873740
[TBL] [Abstract][Full Text] [Related]
9. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
[TBL] [Abstract][Full Text] [Related]
10. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
12. The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea.
Barbato M; Maiella G; Di Camillo C; Guida S; Valitutti F; Lastrucci G; Mainiero F; Cucchiara S
Dig Liver Dis; 2011 Jun; 43(6):465-9. PubMed ID: 21257356
[TBL] [Abstract][Full Text] [Related]
13. [Serological diagnosis of celiac disease].
Roujon P; Sarrat A; Contin-Bordes C; Pellegrin I; Guidicelli G; Taupin JL; Moreau JF; Blanco P
Pathol Biol (Paris); 2013 Jun; 61(3):e39-46. PubMed ID: 21621349
[TBL] [Abstract][Full Text] [Related]
14. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and clinical presentations of celiac disease: a multicenter study].
Canales R P; Araya Q M; Alliende G F; Hunter M B; Alarcón O T; Chávez S E
Rev Med Chil; 2008 Mar; 136(3):296-303. PubMed ID: 18575654
[TBL] [Abstract][Full Text] [Related]
16. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
[TBL] [Abstract][Full Text] [Related]
17. IgA anti-tissue transglutaminase antibodies, first line in the diagnosis of celiac disease.
Samaşca G; Iancu M; Farcău D; Butnariu A; Pop T; Pîrvan A; Andreica M; Miu N; Cristea V; Dejica D
Clin Lab; 2011; 57(9-10):695-701. PubMed ID: 22029184
[TBL] [Abstract][Full Text] [Related]
18. Progress in the serology-based diagnosis and management of adult celiac disease.
Penny HA; Raju SA; Sanders DS
Expert Rev Gastroenterol Hepatol; 2020 Mar; 14(3):147-154. PubMed ID: 32011187
[No Abstract] [Full Text] [Related]
19. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
